Behçet's disease surgery
|
Behçet's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Behçet's disease surgery On the Web |
|
American Roentgen Ray Society Images of Behçet's disease surgery |
|
Risk calculators and risk factors for Behçet's disease surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2] Dheeraj Makkar, M.D.[3]
Overview
Surgery in Behcet's disease is performed to treat severe complications such as gastrointestinal perforations or ocular inflammatory diseases.
Surgery
- Vascular Surgery
Indications:
Arterial aneurysms (especially aortic or pulmonary artery aneurysms).
Severe stenosis or thrombotic occlusion requiring revascularization.
Challenges:
High risk of postoperative complications such as prosthetic thrombosis or anastomotic dehiscence.
Surgical interventions should not be performed without prior immunosuppressive therapy.
Key recommendation:
Preemptive immunosuppressive treatment (e.g., glucocorticoids, azathioprine, cyclophosphamide, or TNF inhibitors) is essential to lower the risk of surgical complications.
- Gastrointestinal Surgery
Indications:
Life-threatening complications such as perforation, massive hemorrhage, or severe obstruction.
Challenges:
Behçet’s-related ulcers can impair healing.
Surgery carries a high risk of adverse postoperative outcomes (e.g., recurrence at anastomotic sites).
Key recommendation:
Concomitant immunosuppressive therapy is advised even in surgical cases to reduce postoperative complications and relapse risk.
- General Surgical Considerations
Surgery in Behçet’s is considered high-risk because of the underlying vasculitis and systemic inflammation.
Whenever possible, medical management is preferred (e.g., immunosuppressants, biologics).
If surgery is unavoidable, close coordination with rheumatology/immunology teams is necessary for perioperative immunosuppression.
Summary
Vascular surgery (aneurysm repair, revascularization) and GI surgery (for perforation/bleeding) may be required in Behçet’s, but they carry significant risks.
The NEJM article emphasizes that surgery must be coupled with immunosuppressive therapy to prevent recurrence, thrombosis, or anastomotic complications Surgery may help treat patients of Behçet's disease with severe complications, such as gastrointestinal perforation or ocular inflammatory diseases.[1][2]
References
- ↑ Jo JH, Park SJ, Cheon JH, Kim TI, Kim WH (2018). "Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Behçet's disease". J Gastroenterol Hepatol. 33 (2): 375–379. doi:10.1111/jgh.13855. PMID 28666309.
- ↑ Tugal-Tutkun I, Onal S, Ozyazgan Y, Soylu M, Akman M (2014). "Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Behçet uveitis". Ocul Immunol Inflamm. 22 (6): 461–8. doi:10.3109/09273948.2013.854393. PMID 24329561.